Brand Story
Harvard Apparatus Regenerative Technology was jointly founded in 1901 by Harvard University and Harvard Medical School. The organization was established with the mission of advancing the application and commercialization of cutting-edge global medical research achievements.
With 124 years of dedication to anti-aging and regenerative medicine, the company has remained at the forefront of research aimed at expanding human health and longevity.
Our Story
1901
Professor William Butt of Harvard Medical School led the founding of Harvard Bioscience, focusing on regenerative medicine and longevity research.
2002
Harvard Bioscience was listed on NASDAQ.
- 2003 & 2013: The effectiveness of Resveratrol and NMN in anti-aging was successively validated.
2008
Integrated the regenerative medicine and preventive medicine business segments.
2010
Achieved the first successful animal experiment in tubular organ regeneration.
2013
- Reorganized the regenerative medicine and preventive medicine divisions.
- The company was listed on NASDAQ under the name Harvard Apparatus Regenerative Technology.
2023
- Focused preventive medicine efforts on anti-aging products and began entering the Chinese market.
2017
- Made a groundbreaking advancement in regenerative medicine by completing the world’s first human esophageal regeneration implant surgery.
